key: cord-0761145-up783i3a authors: Puntillo, Filomena; Giglio, Mariateresa; Brienza, Nicola; Viswanath, Omar; Urits, Ivan; Kaye, Alan D.; Pergolizzi, Joseph; Paladini, Antonella; Varrassi, Giustino title: Impact of Covid-19 pandemic on chronic pain management: looking for the best way to deliver care date: 2020-07-17 journal: Best Pract Res Clin Anaesthesiol DOI: 10.1016/j.bpa.2020.07.001 sha: 20a45d67372ec5d7ddd4c079a254fecf4345180f doc_id: 761145 cord_uid: up783i3a Although pain treatment has been described as a fundamental human right, the COVID-19 pandemic forced health care systems worldwide to redistribute health care resources towards intensive care units and other COVID-19 dedicated sites. As most chronic pain services were subsequently deemed non-urgent, all outpatient and elective interventional procedures have been reduced or interrupted during the COVID-19 pandemic in order to reduce the risk of viral spread. The shutdown of pain services jointly to the home lockdown imposed by governments, has affected chronic pain management worldwide with additional impact on patients’ psychological health. The aim of this review, therefore, is to analyze the impact of COVID-19 pandemic on chronic pain treatment and to address what types of strategies can been implemented or supported in order to overcome imposed limitations in delivery of chronic pain patient care. Although pain treatment has been described as a fundamental human right, the COVID-19 pandemic forced health care systems worldwide to redistribute health care resources towards intensive care units and other COVID-19 dedicated sites. As most chronic pain services were subsequently deemed non-urgent, all outpatient and elective interventional procedures have been reduced or interrupted during the COVID-19 pandemic in order to reduce the risk of viral spread. The shutdown of pain services jointly to the home lockdown imposed by governments, has affected chronic pain management worldwide with additional impact on patients' psychological health. The aim of this review, therefore, is to analyze the impact of COVID-19 pandemic on chronic pain treatment and to address what types of strategies can been implemented or supported in order to overcome imposed limitations in delivery of chronic pain patient care. Key Words: Chronic pain, COVID-19, Telemedicine, Interventional Pain Chronic pain is commonly defined from the International Association for the Study of Pain (IASP) as persistent or recurrent pain lasting more than 3 months or beyond the normal tissue healing (1) . The overall prevalence of chronic pain in the general population is around 20% (2, 3, 4, 5, 6) . Its burden is huge in terms of personal and socioeconomic costs (7) . Disability, emotional imbalances and social isolation are frequently associated with chronic pain often resulting in a vicious circle that compromises quality of life (QoL) of affected patients (8, 9) . Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 (e.g., severe acute respiratory syndrome coronavirus 2), a coronavirus related to the SARS source from 2003. Pharyngodynia, dry cough and fever, are the initial symptoms of a mild respiratory tract infection; however, in some cases, it may rapidly progress to respiratory distress requiring intensive care unit admission and ventilatory support with fatal outcome in 1.8-3.4% of cases (10) . Pain can be an early symptom of COVID-19 infection including myalgias, back pain, and headache (11) . In addition to age, other risk factors for severe COVID-19 disease include smoking, pulmonary disease, congestive heart failure, diabetes, AIDS and hematological disease. The outbreak of COVID-19 in the first months of 2020 from Wuhan to Europe and the USA, imposed a strategy for infection control consisting worldwide of a ban in gathering, home isolation, and stoppage in all non-essential social services, including non-urgent health care. Although pain treatment has been described as a fundamental human right (12) , the COVID-19 pandemic forced health care systems worldwide to redistribute health care resources towards intensive care units and other COVID-19 dedicated sites. As most chronic pain services were deemed non-urgent, all outpatient and elective interventional procedures have been reduced or interrupted during the COVID-19 pandemic in order to reduce the risk of viral spread. The shutdown of pain services jointly to the home lockdown imposed by governments, has affected chronic pain management worldwide with additional impact on patients' psychological health. The aim of this review, therefore, is to analyze the impact of COVID-19 pandemic on chronic pain treatment and to address what types of strategies can been implemented or supported in order to overcome imposed limitations in delivery of chronic pain patient care. Chronic pain is a complex multidimensional experience severely compromising quality of life often limited ability to work, sleep, and affected social interactions with friends and family. According to the eleventh International Classification of Diseases (ICD-11), chronic pain can be classified into seven categories: primary, cancer related, post-traumatic, postsurgical, neuropathic, visceral, musculoskeletal, and headache/orofacial (13) . The meaning of chronicity is far beyond the temporal criterion; chronic pain is a real "disease" associated with multiple adaptations in the nervous, endocrine and immune systems (14, 15, 16) . Many factors have been associated with the development of chronic pain including demographic ones (e.g., age, ethnicity, occupational factors), lifestyles (e.g., smoking, alcohol, physical activity), physical and mental health, genetics, history of abuse or violence and also coping strategies (17) . With the aging of our population, the prevalence of chronic pain in older patients is increasing (4) . Multi-morbidity is independently associated with chronic pain; up to 88% of patients with chronic pain have other comorbidities such as depression (18) , cardiovascular and pulmonary disease, diabetes mellitus, and cancer (19, 20) . Comorbidities increase the risk of side effects of analgesics limiting the applicability of disease-specific clinical guidelines and making it more challenging to obtain good pain control (21) . Moreover, in people with other co-morbidities, chronic pain is an independent risk factor for mortality (22) . Overall, chronic pain is considered the leading cause of disability and is associated with high economic and social burden. In this regard, low back and neck pain are the most frequent syndromes associated with disability, but other chronic pain conditions are identified in the top ten list (23) . As a consequence of disability, untreated chronic pain can cause job loss, economic problems, depressive mood, and social isolation. Cognitive, affective and emotional disorders have been found in many chronic pain patients causing complex biopsychosocial interactions (24) . All these features have been even more exacerbated during the COVID-19 pandemic, contributing to make the delivery of effective pain management more challenging. From one side patients tend to stay away from hospitals related to fear of infection, so that acute pain is largely untreated and can more easily progress to chronic pain, increasing the risk of disability and depressive status. On the other side, social isolation imposed during the pandemic can promote passive coping strategies, with further worsening of depressive mood, and increasing suicidal ideation. Therefore, in this global health pandemic, risk factors for pain morbidity and mortality have be amplified. Several challenges have emerged during the COVID-19 pandemic for pain physicians, both in terms of risks of harm from undertreatment, as well as risk of harm from inappropriate treatment, since interaction between pain medications and the immune system must be considered. Untreated chronic pain can affect the immune system inducing immunosuppression in some patients (25) . Moreover, the association of chronic pain, comorbidities and older age increases the risk of infection including COVID-19 disease. Pain treatments can also compromise the immune system in particular with the use of steroids. Oral or injected steroids can induce secondary adrenal insufficiency altering immune response (26) . Opioids, in general, decrease in a dose-dependent manner natural killer cells and therefore are associated with progression of infectious states. Opioids can also have immunosuppressive effects interfering with innate and acquired immune response acting directly on immune cells (linking MOR and Toll like receptors 4) or indirectly acting on hypothalamic pituitary-adrenal axis (producing corticosteroids) and on the sympathetic nervous system (producing noradrenaline). Both corticosteroids and noradrenaline, acting on leucocytes, also negatively modulate the immune response decreasing natural killer (NK) cell cytotoxicity (27) . Morphine can also act via D1 dopamine receptors in the nucleus accumbens shell, increasing the release of neuropeptide Y (NPY) and reducing splenic NK cell cytotoxicity in rodent models (28) . High dosages and long-term opiate therapy increase the risk of immunosuppression even if with different effects according to the type of opioid, being fentanyl and morphine the most immunosuppressive and the buprenorphine the least (29) . Fentanyl patches can also increase the risk of respiratory depression in case of fever and non-steroidal anti-inflammatory drugs (NSAID) can mask fever and myalgias COVID-19 related. Moreover, the risk of infection for patients, caregivers and also physicians should be considered when planning a pain treatment in COVID-19 era in order to restrict hospital entry and the risk of viral diffusion. Finally, there are some "essential" interventional pain procedures that cannot be postponed: patients with implantable device for intrathecal infusion need the refill of the pump to avoid abstinence syndrome and patients with neurostimulation implants can need check in case of infection or wound dehiscence or lead migration (30, 31) . During the Covid-19 pandemic, new therapeutic challenges have been added to the usual ones (see Table 1 ), and the decision about when and how to treat chronic pain have to be carefully evaluated in any single patient. Table 2 : 2) Triage the risk of COVID-19 screening patients and personnel for symptoms of COVID-19. 3) Triage the pain procedures in elective, urgent and emergent: suspend elective cases, proceed with emergent ones and consider case by case in urgent situation. taken into consideration according to several factors, such us acuity and severity of pain, whether or not the patient has comorbid psychiatric condition, occupational consideration (such as whether the patient is also a caregiver or has children), the likelihood of the visit/procedure providing meaningful benefit, the likelihood of the patient to seek emergency services, or be started on opioids, and the need for physical examination. Adapt ongoing therapy to reduce the risk on COVID-19. 6) Perform urgent procedures with the minimal number of personnel, ideally by a single physician avoiding deep sedation requiring airway support. 6) Consider intrathecal pump refill an emergent interventional pain procedure. In some cases, inhome pump refill can be planned. The peculiarity of pain services is the delivering of a face-to-face service being an in-person visit imperative at the first consultation, in order to assess pathophysiology of pain referenced by the patient. During the COVID-19 pandemic, the needs to contain coronavirus spread on one side and to guarantee the continuity of care to the other, have made it necessary to utilize the remote treating of patients with non-urgent conditions and/or long-term disease. if there are some concerns about privacy protection and data security (38) . Even in pediatrics, mHealth associated with virtual reality has been implemented for procedural pain and for assessing pain in children's cancer pain with the aid of three-dimensional avatars (39) . Web-based systems like Collaborative Health Outcome Information Registry (40) or PAIN OUT (41) have been optimized for people with pain. CHOIR is a platform intended to optimize care and advance real-world research permitting a basic multidisciplinary assessment of the patient before even meeting him or her. PAIN OUT is an international registry project born to improve the treatment of patients with post-operative pain. Unfortunately, the pandemic has stressed the efficiency of these web-based systems. Moreover, differently form the other vital signs, pain, the fifth vital sign, is inherently subjective, so that the reporting of pain experience is extremely variable between patients. Elderly, disabled patients, and patients with cognitive or emotional disorders including opioid addiction can miss remote control or make it more difficult (42) . These collectively represent challenges for telemedicine to overcome. As a matter of fact, the evidence on telemedicine efficacy in chronic pain is lacking according to some published systematic reviews (43, 44) , including a Cochrane review (45) . The effects of psychological therapies delivered via the Internet on pain, disability, depression and anxiety are promising but come from a small number of trials so that the estimate of the effects remains to be assessed. However, to maximize eHealth effectiveness there is the need of training not only the patients and also the practitioners accustomed to a face-to-face relationship and the need of a rapid integration of remotely supported pain management services. The COVID-19 pandemic has strained the importance of a biopsychosocial approach to pain: online self-management programs integrating healthy lifestyles and active strategies of coping, like exercises, can represent a good opportunity. Even though opioid prescription telemedicine represents a useful means to evaluate the opportunity of beginning or continuing opioid prescription, telehealth also can address Opioid Use Disorder (OUD) at home (46) . Another important opportunity for telemedicine is the assessment and treatment of emotional distress related to the COVID-19 pandemic itself. Table 3 displays the possible use of telemedicine during To provide a safe and effective service To triage the urgency of an in-person visit To evaluate patients and plan treatments To help prescribing opioids To resolve patient concern To perform a biopsychosocial management of pain To assess and treat emotional distress pain related or pandemic related (47) . Increasing evidence has demonstrated that SARS-CoV-2 has the ability to invade the nervous system above all in immunocompromised patients (48) . According to recent studies, SARS-CoV-2 infection can cause a lot of neurological diseases including viral encephalitis, meningoencephalitis, ischemic stroke, and hemorrhagic stroke (49, 50) . Angiotensin converting enzyme 2 (ACE2) is considered to be a functional receptor for SARS-CoV-2 invasion (51). SARS-CoV-2 binds to the host cells'ACE2 and infects the cells. SARS-CoV-2 sheds nucleic acid from the host to spread, similar to influenza virus. Endothelial cells of blood vessels have high expression of ACE2, and SARS-CoV-2 infection can attack endothelial cells in the cerebral blood vessels through the ACE2 receptor and disrupt the bloodbrain barrier (BBB), resulting in increased permeability of the BBB, cerebral edema, and intracranial hypertension. In addition to invasion by blood vessels, viruses may enter the central nervous system (CNS) through the terminals of the olfactory nerve. Importantly, axonal transport also supports the rapid spread from neuron to neuron (48) . Moreover, two other mechanisms have been proposed in order to explain neurological damage during COVID-19 pneumonia: hypoxic brain injury and an immune mediated damage to the CNS. Systemic hypoxia can cause neuronal swelling and brain edema, which ultimately results in neurological damage. In addition, cytokine storm with increased levels of inflammatory cytokines and activation of T lymphocytes, macrophages, and glial cell can cause neuronal apoptosis, while damage to endothelium and activation of complement and coagulation cascade could render patients prone to cerebrovascular events, both thrombotic and hemorrhagic (52) . According to recent studies, more than 35% of COVID-19 patients develop neurological symptoms. Some COVID-19 patients may present neurologic symptoms as the initial presentation of the disease. Current published studies have suggested that neurological involvement in the pathogenesis of SARS CoV 2 does seem to be associated with a more "severe" infection and subsequent mortality (53) . Therefore, during the current context of the COVID-19 pandemic, physicians should be aware of the wide spectrum of neurological COVID-19 signs and symptoms for early diagnosis and isolation of patients. Moreover, all these neurological manifestations could result in different painful clinical pictures, ranging from peripheral neuralgia to post-stroke pain syndrome, that need to be treated and pose further challenges for pain physicians. The Covid-19 pandemic has stressed health care systems worldwide so that many pain services are no longer open for business. Chronic pain patient populations remain isolated with consequent social and psychological impact. Telehealth represents a good opportunity to avoid "missed care", helping to triage a single case as urgent or emergent and to address pandemic related emotional disorders. This represents an opportunity for all pain physicians to better point out chronic pain patients' needs and how to care for them. Funding: This research has been possible thanks to an unconditional grant provided by the "Paolo Procacci Foundation-ONLUS", Via Tacito 7, 00193 Roma, Italy. Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. -Although pain treatment has been described as a fundamental human right, the COVID-19 pandemic forced health care systems worldwide to redistribute health care resources towards intensive care units and other COVID-19 dedicated sites -The shutdown of pain services jointly to the home lockdown imposed by governments, has affected chronic pain management worldwide with additional impact on patients' psychological health. -Telehealth represents a good opportunity to avoid "missed care", helping to triage a single case as urgent or emergent and to address pandemic related emotional disorders. -Further studies are needed to elucidate the quality of telemedicine visits compared to tradition clinc patient visti -Further investigation is needed to see how self-isolation in times of a pandemic can precipitate chronic pain Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms Prevalence of chronic pain with neuropathic characteristics in the general population Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies Assessment of chronic pain and access to pain therapy: A cross-sectional population-based study Real-world incidence and prevalence of low back pain using routinely collected data Epidemiology of chronic pain in the Latium Region, Italy: A cross-sectional study on the clinical characteristics of patients attending pain clinics The societal impact of pain in the European Union: Health-related quality of life and healthcare resource utilization Pain and depression: an integrative review of neurobiological and psychological factors An overview of treatment approaches for chronic pain management Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore Pain Management During the COVID-19 Pandemic in China: Lessons Learned The Declaration Montreal: access to pain management is a fundamental human right A classification of chronic pain for ICD-11 Cellular and molecular mechanisms of pain Dual peripheral actions of immune cells in neuropathic pain Pain and the immune system Chronic pain: a review of its epidemiology and associated factors in population-based studies Depression and chronic pain in the elderly: Links and management challenges Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a familybased cohort and twin study Epidemiology of multimorbidity and implications for health care, research, and medical education: a crosssectional study Adapting clinical guidelines to take account of multi-morbidity Chronic pain and mortality: a systematic review Global, regional, and na-tional incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990e2016: a systematic analysis for the Global Burden of Disease Study Opioids, sensory systems and chronic pain Role of the immune system in chronic pain Perioperative steroid management: approaches based on current evidence Opioids and the immune system-friend or foe Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review from Animal and Human Studies Emergence from the Coronavirus Disease 2019 Pandemic and the Care of Chronic Pain: Guidance for the Interventionalist Ultrasound-Guided Interventions During the COVID-19 Pandemic-A New Challenge Pain Management Best Practices from Multispecialty Organizations during the COVID-19 Pandemic and Public Health Crises Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study. Lancet Digit Health Medical Advisory Secretariat, Health Quality Ontario. Internet-Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices: An Evidence-Based Analysis WhatsApp in hospital? An empirical investigation of individual and organizational determinants to use Pain Buddy: A Novel Use of M-Health in the Management of Children's Cancer Pain Chronic Pain in the Elderly with Cognitive Decline: A Narrative Review Tailored web-based interventions for pain: systematic review and meta-analysis An evaluation of the effectiveness of the modalities used to deliver electronic health interventions for chronic pain: systematic review with network meta-analysis Psychological therapies (Internet-delivered) for the management of chronic pain in adults Treating Patients with Opioid Use Disorder in Their Homes. An Emerging Treatment Model Guillain Barré syndrome following COVID 19: new infection, old complication? Transmission dynamics and evolutionary history of 2019 nCoV The COVID-19 Pandemic: Consideration for Brain Infection Encephalitis as a clinical manifestation of COVID-19 Angiotensin converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS CoV 2: A double edged sword? Preliminary CT findings of coronavirus disease 2019 (COVID-19) The neurological manifestations of COVID-19: a review article